MIMEDX GROUP INC - COMMON STOCK

MIMEDX Announces Third Quarter 2022 Operating and Financial Results

02 11 2022 16:15:01 提供 Nasdaq GlobeNewswire

MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2

19 10 2022 08:00:01 提供 Nasdaq GlobeNewswire

MIMEDX Appoints Matt Notarianni as Head of Investor Relations

04 10 2022 08:00:01 提供 Nasdaq GlobeNewswire

MIMEDX Announces Launch of AXIOFILL™

20 9 2022 08:00:02 提供 Nasdaq GlobeNewswire

MIMEDX Announces Launch of AMNIOEFFECT™

19 9 2022 07:00:00 提供 Nasdaq GlobeNewswire

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

12 9 2022 16:30:00 提供 Nasdaq GlobeNewswire

MIMEDX Announces Leadership Transition

06 9 2022 07:00:00 提供 Nasdaq GlobeNewswire

Regenerative Engineering Society Establishes Award in Honor of MIMEDX Board Member, Dr. Cato T. Laurencin

26 8 2022 09:00:00 提供 Nasdaq GlobeNewswire

MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference

04 8 2022 16:08:43 提供 Nasdaq GlobeNewswire

MIMEDX Announces Second Quarter 2022 Operating and Financial Results

02 8 2022 16:07:16 提供 Nasdaq GlobeNewswire

MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts

27 7 2022 08:00:01 提供 Nasdaq GlobeNewswire

MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3

20 7 2022 08:00:01 提供 Nasdaq GlobeNewswire

MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer

18 7 2022 09:35:23 提供 Nasdaq GlobeNewswire

MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis

15 6 2022 08:30:00 提供 Nasdaq GlobeNewswire

MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting

07 6 2022 16:05:29 提供 Nasdaq GlobeNewswire

MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders

03 6 2022 08:00:00 提供 Nasdaq GlobeNewswire

MIMEDX Addresses Presentation by Prescience Point

02 6 2022 08:03:35 提供 Nasdaq GlobeNewswire

MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders

31 5 2022 16:05:00 提供 Nasdaq GlobeNewswire

MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns

31 5 2022 08:00:01 提供 Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote “FOR ALL” of the Company’s Proposals

25 5 2022 17:26:30 提供 Nasdaq GlobeNewswire